Evidence map›Paper›PMID 42578050›Full record

ArticleInternational journal of surgery case reports2026

Pulmonary sclerosing pneumocytoma: a case report of a challenging preoperative diagnosis.

Keisuke Tetsumoto, Teruya Komatsu, Akira Hara, Takenobu Gomyo, Tatsuo Kato

Abstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Keisuke TetsumotoDepartment of General Thoracic Surgery, National Hospital Organization Nagara Medical Center, Gifu, Japan.ORCID https://orcid.org/0009-0008-5796-507X
Teruya KomatsuDepartment of General Thoracic Surgery, National Hospital Organization Nagara Medical Center, Gifu, Japan.
Akira HaraDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Takenobu GomyoDepartment of Respiratory Medicine, National Hospital Organization Nagara Medical Center, Gifu, Japan.
Tatsuo KatoDepartment of Respiratory Medicine, National Hospital Organization Nagara Medical Center, Gifu, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pulmonary sclerosing pneumocytoma (PSP), formerly known as sclerosing hemangioma, is a rare tumor that is typically found incidentally and can closely mimic malignancy on imaging and biopsy, making it challenging to distinguish from lung malignancy. Presentation of case: A 67-year-old man presented with an incidental finding of a nodule in the left upper lobe. Chest computed tomography revealed a 2.2-cm, well-circumscribed nodule adjacent to the pulmonary hilum of the upper lobe. Bronchoscopic biopsy suggested adenocarcinoma, and the patient underwent left upper lobectomy with lymph node dissection via posterolateral thoracotomy. Final histopathological findings resulted in a diagnosis of PSP. Discussion: Accurate preoperative diagnosis of PSP is difficult because the tumor contains heterogeneous histologic components, and limited biopsy samples may capture only areas resembling malignancy. As illustrated in this case, preoperative biopsy may lead to misdiagnosis, and complete resection is often required for a definitive diagnosis. Conclusion: This case highlights the diagnostic difficulty of PSP and underscores the importance of considering PSP when evaluating solitary pulmonary nodules. A brief review of the relevant literature is also provided.

Indexed as

adenocarcinomabronchoscopypulmonary sclerosing pneumocytomasurgery

Identifiers

PMID42578050
PMCPMC13456756

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.